Financial Statement Revisions (Tables)

12 Months Ended

Dec. 30, 2017

Prior Period Adjustment [Abstract]

Revisions to Applicable Consolidated Statements of Cash Flows Line Item to correct the errors

The tables below present the revisions to the applicable Consolidated Statements of Cash Flows line item to correct the errors for all periods presented (amounts in thousands):

	Fiscal 2016
Impacted Consolidated Cash Flow Statement line item	As Previously Reported			Revisions			New Guidance(1)		As Revised
Other reconciling items to net income	$	(3,957	)	$	—		$	3,851	$	(106	)
Other assets	$	(11,107	)	$	7,666		$	—	$	(3,441	)
Other accrued liabilities	$	12,389		$	(999	)	$	—	$	11,390
Net cash provided by operating activities	$	346,044		$	6,667		$	3,851	$	356,562
Repurchase of independent distributor territories	$	(10,350	)	$	1,479		$	—	$	(8,871	)
Cash paid at issuance of notes receivable	$	—		$	(8,577	)	$	—	$	(8,577	)
Other investing activities	$	2,091		$	431		$	—	$	2,522
Net cash disbursed for investing activities	$	(70,047	)	$	(6,667	)	$	—	$	(76,714	)

	Fiscal 2015
Impacted Consolidated Cash Flow Statement line item	As Previously Reported			Revisions			New Guidance(1)		As Revised
Other reconciling items to net income	$	(3,425	)	$	—		$	9,134	$	5,709
Other assets	$	(12,899	)	$	8,239		$	—	$	(4,660	)
Net cash provided by operating activities	$	318,301		$	8,239		$	9,134	$	335,674
Repurchase of independent distributor territories	$	(13,768	)	$	(570	)	$	—	$	(14,338	)
Cash paid at issuance of notes receivable	$	—		$	(7,962	)	$	—	$	(7,962	)
Other investing activities	$	839		$	293		$	—	$	1,132
Net cash disbursed for investing activities	$	(461,576	)	$	(8,239	)	$	—	$	(469,815	)

(1) The tables above include the impact of adopting new share-based payment guidance discussed in Note 3, Recent Accounting Pronouncements.